Skip to main content
PLOS ONE logoLink to PLOS ONE
. 2021 Oct 14;16(10):e0258349. doi: 10.1371/journal.pone.0258349

Health risk behaviours among people with severe mental ill health during the COVID-19 pandemic: Analysis of linked cohort data

Emily Peckham 1,*, Victoria Allgar 2, Suzanne Crosland 1, Paul Heron 1, Gordon Johnston 3, Elizabeth Newbronner 1, Panagiotis Spanakis 1, Ruth Wadman 1, Lauren Walker 1, Simon Gilbody 1,2
Editor: Jagdish Khubchandani4
PMCID: PMC8516268  PMID: 34648548

Abstract

Background

People with severe mental ill health (SMI) experience a mortality gap of 15–20 years. COVID-19 has amplified population health inequalities, and there is concern that people with SMI will be disproportionately affected. Understanding how health risk behaviours have changed during the pandemic is important when developing strategies to mitigate future increases in health inequalities.

Methods

We sampled from an existing cohort of people with SMI. Researchers contacted participants by phone or post to invite them to take part in a survey about how the pandemic had affected them. We asked people about their health risk behaviours and how these had changed during the pandemic. We created an index of changed behaviours, comprising dietary factors, smoking, lack of exercise, and drinking patterns. By creating data linkages, we compared their responses during pandemic restrictions to responses they gave prior to the pandemic.

Outcomes

367 people provided health risk data. The mean age of the participants was 50.5 (range = 20 to 86, SD ± 15.69) with 51.0% male and 77.4% white British. 47.5% of participants reported taking less physical activity during the pandemic and of those who smoke 54.5% reported smoking more heavily. Self-reported deterioration in physical health was significantly associated with an increase in health risk behaviours (adjusted OR for physical health 1.59, 95%CI 1.22–2.07; adjusted OR for Age 0.99, 95%CI 0.98–1.00).

Interpretation

COVID-19 is likely to amplify health inequalities for people with SMI. Health services should target health risk behaviours for people with SMI to mitigate the immediate and long lasting impacts of the COVID-19 pandemic.

Introduction

The COVID-19 pandemic is likely to impact on public health in ways that extend beyond the number of deaths attributable to coronavirus [1, 2]. One possible impact on public health is a change in health related behaviours, which may be affected by the social measures introduced to limit the spread of the virus (pandemic restrictions) such as minimizing social contacts and staying at home. The pandemic restrictions, coupled with daily news coverage of the number of COVID-19 related deaths, are likely to impact on people in a variety of ways. For example, the perceived risks of contracting COVID-19 may provide a ‘teachable moment’ that acts as a prompt to encourage people to make changes to their behaviour; such as cutting down on drinking alcohol and smoking or increasing physical activity [3]. On the other hand, concerns about COVID-19 may lead people to avoid undertaking physical activity outdoors and lead more sedentary lives. Additionally concerns around contracting the virus, increased social isolation or the stress as a result of the pandemic restrictions may lead some people to drink and smoke more and find it more difficult to make healthy food choices [4]. Furthermore, access to healthy food may have become more difficult due to fears about supermarkets, difficulty in assessing online food shopping and closure of cafes and community projects where people may have accessed healthy meals. In addition, the closure of gyms and swimming pools may have impacted on physical activity levels [5].

Understanding the impacts of the pandemic restrictions on health-related behaviours is important for assessing the wider public health consequences of the pandemic[6]. In turn this is also helpful in informing how these impacts can be mitigated. Addressing health risk behaviours remains a public health priority [7, 8]. Smoking, excessive alcohol consumption, physical inactivity and obesity [911] are some of the leading causes of disease and premature death worldwide. The effects of the pandemic on health related behaviours in the general population have been mixed. It has been reported that in the early stages of the pandemic 300,000 quit (smoking) for Covid [12], yet the percentage of people who smoke in the general population remains very similar to the figure before the pandemic [13]. A similar picture has been reported for alcohol consumption, with high risk drinkers being more likely to report trying to reduce their alcohol consumption at the start of the pandemic. However, the prevalence of high risk drinking has increased [13]. A study looking at behaviours around weight and physical activity has shown comparable results, with some people reporting having undertaken more physical activity and others reporting taking less [4]. A study in Spain has shown that, the early stages of the pandemic, people who meet the WHO guidelines for physical activity are have lower perceived anxiety and lower perceived worse mood [14]. Importantly, studies have generally demonstrated that the pandemic restrictions may have a disproportionately large influence on behaviours which cause weight gain among adults with a pre-existing higher BMI [4], and among people from lower socio-economic groups and with pre-existing conditions [15].

It is possible that the pandemic and its associated restrictions will amplify already existing health inequalities; people with severe mental ill health (SMI) are one such group that may be adversely affected [16]. People with SMI currently experience a mortality gap of 15–20 years when compared to people without SMI [17, 18]. One of the major drivers of this health gap is preventable physical health conditions linked to behavioural risk factors such as smoking, low physical activity and nutritionally-poor diet. Although studies have explored the impacts of the pandemic and pandemic restrictions on the general population [4, 13, 15, 19] there have, to the best of our knowledge, been no studies that have explored the health related behaviours among people with SMI.

People with SMI are an especially vulnerable group who already experience significant health inequalities. Understanding the specific difficulties encountered by people with SMI becomes critical in identifying how to best to mitigate the risks of them experiencing further deprivation and disadvantage during the current pandemic and beyond. People with SMI are also under-researched with respect to health and health related behaviours, and we were able examine this issue with respect to the COVID pandemic using a large clinical cohort which was recruited in the years immediately prior to the pandemic restrictions [20].

Therefore, the aim of this study was to examine self-reported changes in a range of health related behaviors before vs during the pandemic in a transdiagnostic sample of people with SMI. This is an exploratory study rather than being derived from a theoretical framework.

Design

The Closing the Gap (CtG) study is a large (n = 9, 914) transdiagnostic clinical cohort recruited between April 2016 and March 2020. Participants have documented diagnoses of schizophrenia or delusional/psychotic illness (ICD 10 F20.X & F22.X or DSM equivalent) or bipolar disorder (ICD F31.X or DSM-equivalent). The composition of the CtG cohort has previously been described [20], and the data at inception included descriptions of self-reported alcohol consumption, consumption of fruit and vegetables, participation in physical activity, smoking behavior and e-cigarette use.

We were funded to explore the impact of the COVID-19 pandemic in a sub-section of the CtG clinical cohort and we identified participants for Optimising Well-being in Self-Isolation study (OWLS) [21]. To ensure that the OWLS COVID-19 sub-cohort was captured a range of demographics we created a sampling framework based on gender, age, ethnicity and whether they were recruited via primary or secondary care. OWLS participants were recruited from 17 mental health trusts (across urban and rural settings in England).

Recruitment and participants

Ethical approval was granted by the Health Research Authority North West—Liverpool Central Research Ethics Committee (REC reference 20/NW/0276). To be eligible to take part in OWLS COVID-19 study, people had to be aged 18 or over, to have taken part in CtG study and have consented to be contacted again to be invited to further research. This enabled us to create longitudinal data linkage and to rapidly identify participants during the COVID-19 pandemic.

Procedure

People who met the eligibility criteria were contacted by telephone or letter and invited to take part in the OWLS COVID-19 study. Those who agreed to take part were provided with a range of options; i. to carry out the survey over the phone with a researcher, ii. to be sent a link to complete the survey online or iii. to be sent a hard copy of the questionnaire in the post to complete and return. The questionnaire can be found in S1 File. In the questionnaire before the pandemic refers to before the pandemic restriction came into force in the UK on the 23rd March.

Changes in health related behaviours

Participants were asked about five health related behaviours; (1) alcohol consumption, (2) levels of physical activity, (3) fruit and vegetable consumption, (4) vaping and e-cigarette use, and (5) smoking. For each health related behaviour participants were asked about how often they engaged in that behaviour compared to before the pandemic and could chose from the following options; I don’t do that in general, more than before, about the same or less than before. For physical activity and fruit and vegetable consumption a response of ‘less than before’ was considered to be a negative change in behaviour and for drinking, smoking a response of more than before was considered to be a negative change in behaviour. A cumulative index of harmful health related behaviours were calculated from 0 to 4, [22] we did not include vaping in this metric as vaping could be seen as a positive change if it led to a harm reduction or abstinence from more harmful tobacco use [23].

Self-reported changes in health during pandemic restrictions

For both physical health and mental health study participants were asked ‘compared to your life before the pandemic restrictions, how would you rate your health in general, ‘ with the following response options; ‘better than before’, ‘about the same’, ‘worse than before’, ‘not sure/ don’t know’. After excluding the participants who reported ‘not sure/ don’t know’, a binary variable was derived coded as ‘decline in health’ (including those reporting worse than before) and ‘no decline’ (including those reporting better than before or about the same).

Wellbeing

To align with general population estimates of health related behaviour, study participants were asked four questions taken from the ONS Health and Lifestyle Survey (HLS) [24] about how they had been feeling with a response option scored on a Likert scale of 0–10. The questions asked were; (1) overall how satisfied are you with your life, (2) overall to what extent do you feel that the things you do in your life are worthwhile, (3) overall how happy did you feel yesterday and overall how anxious did you feel yesterday. For the first three questions a score of 0 indicated not at all and a score of 10 completely and for the final question a score of 0 indicated not at all anxious and 10 indicated completely anxious. After reversing the scores for the anxiety question the scores for the four questions were totaled to give a total wellbeing score (0–40), with higher scores indicating greater wellbeing.

Ethnicity

Ethnicity was used to define a binary minority variable (BAME (Black, Asian and minority ethnic) and non-BAME). As people form BAME backgrounds are more at risk from COVID-19 [25] we wanted to determine whether they were also more at risk from health risk behaviours.

Indices of multiple deprivation

We used postcodes already collected at the point of inception to the CtG study to determine levels of deprivation using the level of deprivation assigned to postcodes by the Ministry of Housing, Communities and Local Government [26]. Scores are given between 1 and 10 and then reduced these scores to give five possible outcomes; very high deprivation (1 and 2), high deprivation (3 and 4), moderate deprivation (5 and 6), low deprivation (7 and 8) and very low deprivation (9 and 10).

Statistical analysis

The study analysis plan was registered on Open Science Framework (available at https://doi.org/10.17605/OSF.IO/E3KDM—section 2.1). Analyses were undertaken using SPSS v.26. Descriptive statistics were used to describe sociodemographic characteristics, wellbeing, changes in physical and mental health, health related behaviours, and whether the person was currently receiving support from mental health services. We planned to test (using multiple regression) whether the cumulative index of harmful behaviours was associated with wellbeing and deterioration in physical or mental health after adjusting for age, gender, minority status, socio-economic deprivation and being seen in secondary care. However, as the outcome variable was a count variable (0–4) with 40.3% scoring 0 we used a Poisson regression instead. Predictors were examined individually in univariate models (unadjusted models) before entered into the multivariate model (adjusted model).

Results

Between July and December 2020 367 people from the CtG study were recruited to the OWLS COVID-19 study. From the 2,932 participants in the CtG study that were eligible to be invited to OWLS, we selected a sample of 1,166 (39.8%) participants to attempt to contact and successfully contacted 688 (59%). The survey was completed by 367 participants (31.5% of those eligible to be invited and 53.3% of those successfully contacted) see Fig 1—Flow Diagram.

Fig 1. Flow diagram.

Fig 1

Table 1 describes the socio-demographic characteristics of OWLS participants. The mean age was 50.5 (range = 20 to 86, SD ± 15.69) with 51.0% male and 77.4% white British.

Table 1. Demographic characteristics of OWLS COVID-19 study SMI population during pandemic restrictions.

Characteristic N(%) total n = 367
Self- reported gender
Male 187 (51.0)
Female 174 (47.4)
Transgender 6 (1.6)
Missing 0 (0.0)
Age (mean, range, SD) 50.5 (20–86) (15.7)
Ethnicity
White British 284 (77.4)
Other white 18 (4.9)
Mixed white/ black 5 (1.4)
Mixed white/ Asian 5 (1.4)
Other mixed 4 (1.1)
Asian 24 (6.5)
Black 15 (4.1)
Other non-white 12 (3.3)
Missing 0 (0.0)
Index of deprivation
Very high deprivation 97(26.4)
High deprivation 81 (22.1)
Moderate deprivation 67 (18.3)
Low deprivation 55 (15.0)
Very low deprivation 52 (14.2)
Missing 0 (0.0)
Being seen in secondary
care
Yes 224 (61.0)
No 139 (37.9)
Missing 0 (0.0)
Wellbeing score (mean, SD) 23.1 (8.74)

Table 2 shows the self-reported health related behaviours measured in the CTG study prior to the pandemic. It also shows the changes in health related behaviours and mental and physical health measured in the OWLS COVID-19 study since the beginning of the pandemic. In terms of negative behaviour changes, 29.1% of those who drink reported drinking more than before the pandemic, 54.5% of those who smoke reported smoking more, 47.5% who take part in physical activity reported doing less physical activity and 21.2% of those who eat fruit and vegetables reported eating less fruits and vegetables.

Table 2. Self-reported health and health risk behaviours for the OWLS COVID-19 study participants.

N (%) total n = 367
Drinking and alcohol use
Pre-COVID-19
 Doesn’t drink alcohol 147 (40.1)
 Drinks more than 14 units per week 28 (7.6)
 Missing 64 (17.4)
During COVID-19
I don’t do that in general 197 (53.7)
Those who report drinking alcohol 165 (45.0)
 More than usual 48 (29.1)
 About the same 72 (43.6)
 Less than usual 45 (27.3)
 Missing 5 (1.4)
Smoking and tobacco use
Pre-COVID-19
 People who smoke 114 (31.1)
 People who used to smoke 110 (30.0)
 People who have never smoked 140 (38.1)
 Missing 3 (0.8)
During COVID-19
I don’t do that in general 259 (70.6)
Those who report smoking 99 (27.0)
 More than usual 54 (54.5)
 About the same 33 (33.3)
 Less than usual 12 (12.1)
 Missing 9 (2.5)
Vaping and e-cigarette use
I don’t do that in general 309 (84.2)
Those who report vaping 47 (12.8)
 More than usual 21 (44.7)
 About the same 20 (42.6)
 Less than usual 6 (12.8)
 Missing 11 (3.0)
Taking part in physical activity
Pre-COVID-19
 Never take part in physical activity 74 (20.2)
 Takes part in physical activity 288 (78.5)
 Met government guidelines 156 (42.5)
 Missing 5 (1.4)
During COVID-19
I don’t do that in general 67 (18.3)
Those who report taking part in physical activity 295 (80.4)
 More than usual 61 (20.7)
 About the same 94 (31.9)
 Less than usual 140 (47.5)
 Missing 5 (1.4)
Eating 5 portions of fruit and veg per day
Pre-COVID-19
 Don’t eat fruit and veg 63 (17.2)
 Eats fruit and veg 296 (80.7)
 Met government guidelines 16 (4.4)
 Missing 8 (2.2)
During COVID-19
I don’t do that in general 77 (21.0)
Those who report eating fruit and veg 274 (77.4)
 More than usual 38 (13.4)
 About the same 188 (66.2)
 Less than usual 58 (20.4)
 Missing 6 (1.6)
Self reported global mental health
 No deterioration 210 (57.2)
 Deterioration 148 (40.3)
 Missing 2 (0.5)
Self-reported global physical health
 No deterioration 236 (64.3)
 Deterioration 118 (32.2)
 Missing 2 (0.5)

Table 3 shows the cumulative index of harmful health related behaviour changes reported by participants. 40.3% (148/367) reported no negative behaviour changes, while out of the 56.4% (207/367) who did, 62.8% reported 1 negative behavior change.

Table 3. Cumulative index of self-reported behaviours harmful to health for the OWLS COVID-19 study participants.

n (%) total n = 367
No reported changes in behaviours known to be harmful to health 148 (40.3)
One or more changes in behaviours known to be harmful to health 207 (56.4)
 1 130 (62.8)
 2 67 (32.4)
 3 9 (4.3)
 4 1 (0.5)

We found that self-reported deterioration in physical health was significantly associated with an increase in behaviours known to be harmful to health (Table 4), (adjusted OR for physical health 1.59, 95%CI 1.22–2.07).

Table 4. Associations between socio-demographic factors, health related variables and behaviours known to be harmful to health.

Odds ratio (95% CI) P
Age 0.99 (0.98–1.00) 0.03
Wellbeing score 1.00 (0.98–1.01) 0.72
Self reported gender
Male 1
Female 1.01 (0.79–1.31) 0.89
Transgender 0.67 (0.25–1.85) 0.44
Self-reported ethnicity
Non BAME 1.06 (0.75–1.50) 0.74
BAME 1
Level of deprivation
Very low deprivation 1.13 (0.78–1.63) 0.51
Low deprivation 0.84 (0.57–1.24) 0.38
Moderate deprivation 0.79 (0.54–1.15) 0.22
High deprivation 0.91 (0.65–1.28) 0.59
Very high deprivation 1
Ongoing contact with secondary care
Yes 1.04 (0.80–1.34) 0.78
No 1
Self-reported decline in physical health
Decline 1.59 (1.22–2.07) 0.00*
No decline 1
Decline in mental health
Decline 1.28 (0.96–1.69) 0.09
No decline 1

*indicates statically significant difference.

Discussion

In the transdiagnostic study sample of adults with severe mental ill health (N = 367) we explored behaviours known to be harmful to health and how these may have changed during the COVID-19 pandemic. To the best of our knowledge this is the first study to explore health related behaviours in this population. Prior to the pandemic 20.2% of participants reported that they did not take part in physical activity, this is compared to 18% who reported that they did not take part in physical activity during the pandemic. Of those that were physically active during the pandemic 47.5% report that they are doing less than they did prior to the pandemic. This compares to 36.2% of adults in the general population who reported taking part in less physical activity during the pandemic [15]. This is a cause for concern in a population with already low baseline levels of physical activity and high levels of sedentary behaviour [27]. Furthermore, prior to the pandemic only 4.4% of CtG study participants were meeting government guidelines of five portions of fruit and vegetables per day. During the pandemic 20.4% of people reported eating fewer than before the pandemic. This is a slight improvement over a general population sample (4) that reported 35% of respondents saying they were eating a healthy balanced diet less than before the pandemic. However, it should be borne in mind the low baseline that people with SMI are starting from in terms of fruit and vegetable consumption.

In terms of smoking, the number of people who reported being smokers during the pandemic was nearly double that of the general population. Twenty seven percent in our sample compared to 14.8% in a general population representative sample [19]. However this number has decreased slightly from when participants in the OWLS COVID-19 study were recruited to the CtG cohort (between 2016 and 2020), when the percentage that smoked was 31.4%. Of concern is the fact that of those who do smoke 54.5% were smoking more during the pandemic. More encouragingly, we found that drinking alcohol is of relatively low prevalence amongst our study sample, prior to the pandemic 40.1% of people reported not drinking alcohol compared to 53.7% who reported not drinking alcohol during the pandemic. However, of those that do drink 29.1% were drinking more during the pandemic. These results however should be interpreted with caution as some people in this study are taking medication that contradicts the consumption of alcohol and therefore it may be that some people who drink alcohol did not want to report that they consumed alcohol.

Over half of the OWLS COVID-19 study sample reported greater levels of behaviours known to be harmful to health during the pandemic restrictions. In particular, they reported smoking more, drinking more, eating less fruit and vegetables or taking part in less physical activity. The majority of people had only one increase in behaviour harmful to health, although just under a third had an increase in two behaviours known to be harmful to health. When we explored associations with behaviours known to be harmful to health we found that a reporting a deterioration in physical health was associated with increased health risk behaviour. However, reporting a deterioration in mental health was not found to be associated with behaviours known to be harmful to health. Socio-demographic factors (BAME, IMDD, gender) were also not found to be associated with behaviours known to be harmful to health. We do not know whether an increase in health risk behaviours led to a deterioration in physical health or whether a deterioration in physical health led to people being less able to take care of themselves, and this relationship is likely to be bidirectional. The relationship between physical health and health related behaviours highlights the importance of developing and maintaining strategies to improve the physical health of people with SMI. In addition, younger age was found to be a potential predictor of new behaviours known to be harmful to health under the pandemic. This may be explained by a number of factors, it could be that older people perceive themselves to be more at risk from COVID-19 and are therefore less likely to adopt additional behaviours known to be harmful to health. Younger people may have been more likely to take part in physical activity, which had to stop as the gyms closed and sports clubs couldn’t meet. Another possibility is that people with SMI who engage in negative health behaviours are more likely to have a shorter life expectancy, and not survive into older age. This could be a manifestation of the healthy survivor phenomenon observed in cohort studies [28].

This OWLS COVID-19 study has several strengths. First, we report on a group of people who are underrepresented in general population surveys, and yet have some of the highest levels of unmet health needs [29]. People were directly approached to take part in this study using a sampling framework that allowed people from a range of demographics to be invited rather than a self-selected group, which is a risk for online surveys and can lead to selection bias. The problem of potentially unrepresentative self-selected samples in COVID-19 studies has been shown to be a particular limitation in mental health research [30]. Second, the OWLS COVID-19 study participants had previously been recruited to a large transdiagnostic study of people with SMI, and had consented to be contacted about future research. This allowed us to recruit to the OWLS COVID -19 study rapidly in response the COVID-19 pandemic, whilst still using a sampling strategy. This study does however have some weaknesses. First, whilst every effort was made to include the most vulnerable people from what is a vulnerable group we were rarely able to recruit from inpatient settings or people under the care of assertive outreach teams. When potential participants were on an inpatient ward we asked their care team if they could support the person to take part where it was appropriate to do so. Unfortunately there were very few cases where this was possible. We also attempted to include people in community supported living facilities and asked their care team to support them to take part, in some cases this was possible but in others it proved more difficult. Secondly, the survey relies on self-reported data and people may not accurately recall or may not want to accurately answer the question/s. However this is true for any form of survey that does not have a way of verifying the data provided. Thus the results should be interpreted with this in mind. Thirdly, the design used in this study does not allow us to determine the causes of any changes in health related behaviours so we cannot be certain as to why behaviours might have changed.

Conclusion

People with SMI are considered clinically vulnerable, and these concerns predate the COVID-19 pandemic. The results of this study highlight the additional threats to the health of a group of people who already experience profound health inequalities. SMI is listed as an underlying health condition which puts them at greater risk during the COVID-19 pandemic and many people with SMI also have co-morbid physical health conditions which are additional risk factors also listed as underlying health conditions, for example diabetes and obesity [31]. The results around smoking and exercise are especially concerning, as being a smoker and low levels of physical activity are risk factors for poor COVID-19 outcomes [32, 33] and smoking is a possible risk factor for greater transmission [34].

This evidence presented in this paper further emphasises the need for services that target health risk behaviours, such as smoking, diet and physical exercise, for people with SMI to mitigate these high risks of adverse outcomes in the presence of COVID-19 and in the longer term.

Supporting information

S1 Checklist

(DOCX)

S1 File

(PDF)

Acknowledgments

We would like to thank the participants in the OWLS study and NHS mental health staff for their support with this study. Particular thanks go to our partner trust Tees, Esk and Wear Valleys NHS Foundation Trust.

Data Availability

Data cannot be shared publicly because we do not have permission from the Research Ethics Committee to publicly share participant level data. The data that support the findings of this study are available on request from the Closing the Gap Network email: ctg-network@york.ac.uk for researchers who meet the criteria for access to confidential data.

Funding Statement

EP, PS, PH, GJ, EN and SG Medical Research Council (grant reference MR/V028529). https://mrc.ukri.org/funding/ SG Economic and Social Research Council (ES/S004459/1). https://www.ukri.org SG, RW, EN and PS National Institute for Health Research (NIHR200166) https://www.nihr.ac.uk.

References

  • 1.Brooks SK, Webster RK, Smith LE, Woodland L, Wessely S, Greenberg N, et al. The psychological impact of quarantine and how to reduce it: rapid review of the evidence. The Lancet. 2020;395(10227):912–20. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2.Shevlin M, Nolan E, Owczarek M, McBride O, Murphy J, Gibson Miller J, et al. COVID-19-related anxiety predicts somatic symptoms in the UK population. British Journal of Health Psychology. 2020;25(4):875–82. doi: 10.1111/bjhp.12430 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3.Lawson PJ, Flocke SA. Teachable moments for health behavior change: A concept analysis. Patient Education and Counseling. 2009;76(1):25–30. doi: 10.1016/j.pec.2008.11.002 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4.Robinson E, Boyland E, Chisholm A, Harrold J, Maloney NG, Marty L, et al. Obesity, eating behavior and physical activity during COVID-19 lockdown: A study of UK adults. Appetite. 2021;156:104853. doi: 10.1016/j.appet.2020.104853 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5.Kaur H, Singh T, Arya YK, Mittal S. Physical Fitness and Exercise During the COVID-19 Pandemic: A Qualitative Enquiry. Frontiers in Psychology. 2020;11(2943). doi: 10.3389/fpsyg.2020.590172 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 6.López-Bueno R, Calatayud J, Casaña J, Casajús JA, Smith L, Tully MA, et al. COVID-19 Confinement and Health Risk Behaviors in Spain. Frontiers in psychology. 2020;11:1426-. doi: 10.3389/fpsyg.2020.01426 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 7.Adhikari K, Scott LA, Worrell M, Friesen BT, Teare G. A Call to Action: Commercial Tobacco Smoking Cessation Support as a Priority for Health Care Services During the COVID-19 Pandemic. Nicotine & Tobacco Research. 2020. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 8.Clay JM, Parker MO. Alcohol use and misuse during the COVID-19 pandemic: a potential public health crisis? The Lancet Public Health. 2020;5(5):e259. doi: 10.1016/S2468-2667(20)30088-8 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9.Lear SA, Hu W, Rangarajan S, Gasevic D, Leong D, Iqbal R, et al. The effect of physical activity on mortality and cardiovascular disease in 130 000 people from 17 high-income, middle-income, and low-income countries: the PURE study. Lancet. 2017;390(10113):2643–54. doi: 10.1016/S0140-6736(17)31634-3 [DOI] [PubMed] [Google Scholar]
  • 10.Reitsma MB, Fullman N, Ng M, Salama JS, Abajobir A, Abate KH, et al. Smoking prevalence and attributable disease burden in 195 countries and territories: a systematic analysis from the Global Burden of Disease Study 2015. The Lancet. 2017;389(10082):1885–906. doi: 10.1016/S0140-6736(17)30819-X [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 11.Griswold MG, Fullman N, Hawley C, Arian N, Zimsen SRM, Tymeson HD, et al. Alcohol use and burden for 195 countries and territories: a systematic analysis for the Global Burden of Disease Study 2016. The Lancet. 2018;392(10152):1015–35. doi: 10.1016/S0140-6736(18)31310-2 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 12.Action on Smoking and Health. ASH Daily News for 4 May 2020. 2020.
  • 13.Jackson SE, Garnett C, Shahab L, Oldham M, Brown J. Association of the COVID-19 lockdown with smoking, drinking and attempts to quit in England: an analysis of 2019–20 data. Addiction. 2020. doi: 10.1111/add.15295 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14.López-Bueno R, Calatayud J, Ezzatvar Y, Casajús JA, Smith L, Andersen LL, et al. Association Between Current Physical Activity and Current Perceived Anxiety and Mood in the Initial Phase of COVID-19 Confinement. Frontiers in psychiatry. 2020;11:729-. doi: 10.3389/fpsyt.2020.00729 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15.Herbec A, Schneider V, Fisher A, Kale D, Shahab L, Lally P. Correlates of and changes in aerobic physical activity and strength training before and after the onset of COVID-19 pandemic in the UK—findings from the HEBECO study. medRxiv. 2021:2021.01.16.21249925. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 16.Hamada K, Fan X. The impact of COVID-19 on individuals living with serious mental illness. Schizophrenia research. 2020;222:3–5. doi: 10.1016/j.schres.2020.05.054 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 17.Walker ER, McGee RE, Druss BG. Mortality in mental disorders and global disease burden implications: a systematic review and meta-analysis. JAMA Psychiatry. 2015;72(4):334–41. doi: 10.1001/jamapsychiatry.2014.2502 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 18.Hjorthøj C, Stürup AE, McGrath JJ, Nordentoft M. Years of potential life lost and life expectancy in schizophrenia: a systematic review and meta-analysis. Lancet Psychiatry. 2017;4(4):295–301. doi: 10.1016/S2215-0366(17)30078-0 [DOI] [PubMed] [Google Scholar]
  • 19.Tattan-Birch H, Perski O, Jackson S, Shahab L, West R, Brown J. COVID-19, smoking, vaping and quitting: a representative population survey in England. Addiction. 20202. doi: 10.1111/add.15251 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 20.Mishu MP, Peckham EJ, Heron PN, Tew GA, Stubbs B, Gilbody S. Factors associated with regular physical activity participation among people with severe mental ill health. Soc Psychiatry Psychiatr Epidemiol. 2019;54(7):887–95. doi: 10.1007/s00127-018-1639-2 [DOI] [PubMed] [Google Scholar]
  • 21.OWLS Website 2020 [https://sites.google.com/york.ac.uk/owls-study/home.
  • 22.Foster HME, Celis-Morales CA, Nicholl BI, Petermann-Rocha F, Pell JP, Gill JMR, et al. The effect of socioeconomic deprivation on the association between an extended measurement of unhealthy lifestyle factors and health outcomes: a prospective analysis of the UK Biobank cohort. The Lancet Public Health. 2018;3(12):e576–e85. doi: 10.1016/S2468-2667(18)30200-7 [DOI] [PubMed] [Google Scholar]
  • 23.Gilbody S, Peckham E. What does the rise and rise of electronic nicotine delivery systems mean for mental health services? The Lancet Psychiatry. 2020;7(1):11–3. doi: 10.1016/S2215-0366(19)30479-1 [DOI] [PubMed] [Google Scholar]
  • 24.Opinions and Lifestyle Survey methodology [Internet]. Office for National Statistics. 2018 [cited 19th February 2021].
  • 25.Pan D, Sze S, Minhas JS, Bangash MN, Pareek N, Divall P, et al. The impact of ethnicity on clinical outcomes in COVID-19: A systematic review. EClinicalMedicine. 2020;23. doi: 10.1016/j.eclinm.2020.100404 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 26.English indices of deprivation Ministry of Housing Communities & Local Government; 2019 [https://imd-by-postcode.opendatacommunities.org/imd/2019.
  • 27.Stubbs B, Vancampfort D, Hallgren M, Firth J, Veronese N, Solmi M, et al. EPA guidance on physical activity as a treatment for severe mental illness: a meta-review of the evidence and Position Statement from the European Psychiatric Association (EPA), supported by the International Organization of Physical Therapists in Mental Health (IOPTMH). Eur Psychiatry. 2018;54:124–44. doi: 10.1016/j.eurpsy.2018.07.004 [DOI] [PubMed] [Google Scholar]
  • 28.Arrighi HM, Hertz-Picciotto I. The evolving concept of the healthy worker survivor effect. Epidemiology. 1994;5(2):189–96. doi: 10.1097/00001648-199403000-00009 [DOI] [PubMed] [Google Scholar]
  • 29.Lawrence D, Kisely S. Inequalities in healthcare provision for people with severe mental illness. J Psychopharmacol. 2010;24(4 Suppl):61–8. doi: 10.1177/1359786810382058 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 30.Pierce M, McManus S, Jessop C, John A, Hotopf M, Ford T, et al. Says who? The significance of sampling in mental health surveys during COVID-19. The lancet Psychiatry. 2020;7(7):567–8. doi: 10.1016/S2215-0366(20)30237-6 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 31.Muniyappa R, Gubbi S. COVID-19 pandemic, coronaviruses, and diabetes mellitus. American Journal of Physiology-Endocrinology and Metabolism. 2020;318(5):E736–E41. doi: 10.1152/ajpendo.00124.2020 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 32.Hamer M, Kivimäki M, Gale CR, Batty GD. Lifestyle risk factors, inflammatory mechanisms, and COVID-19 hospitalization: A community-based cohort study of 387,109 adults in UK. Brain Behav Immun. 2020;87:184–7. doi: 10.1016/j.bbi.2020.05.059 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 33.Salah HM, Sharma T, Mehta J. Smoking Doubles the Mortality Risk in COVID-19: A Meta-Analysis of Recent Reports and Potential Mechanisms. Cureus. 2020;12(10):e10837–e. doi: 10.7759/cureus.10837 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 34.Hopkinson NS, Rossi N, El-Sayed_Moustafa J, Laverty AA, Quint JK, Freidin M, et al. Current smoking and COVID-19 risk: results from a population symptom app in over 2.4 million people. Thorax. 2021:thoraxjnl-2020-216422. doi: 10.1136/thoraxjnl-2020-216422 [DOI] [PubMed] [Google Scholar]

Decision Letter 0

Stanton A Glantz

15 Jul 2021

PONE-D-21-09538

Health risk behaviours among people with severe mental ill health during the COVID-19 pandemic: analysis of linked cohort data

PLOS ONE

Dear Dr. Peckham,

Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process.

Please submit your revised manuscript by Aug 29 2021 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.

Please include the following items when submitting your revised manuscript:

  • A rebuttal letter that responds to each point raised by the academic editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'.

  • A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'.

  • An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'.

If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter.

If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: http://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols. Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols.

We look forward to receiving your revised manuscript.

Kind regards,

Stanton A. Glantz, PhD

Academic Editor

PLOS ONE

Journal Requirements:

2.

We note that you have indicated that data from this study are available upon request. PLOS only allows data to be available upon request if there are legal or ethical restrictions on sharing data publicly. For information on unacceptable data access restrictions, please see http://journals.plos.org/plosone/s/data-availability#loc-unacceptable-data-access-restrictions.

In your revised cover letter, please address the following prompts:

a) If there are ethical or legal restrictions on sharing a de-identified data set, please explain them in detail (e.g., data contain potentially identifying or sensitive patient information) and who has imposed them (e.g., an ethics committee). Please also provide contact information for a data access committee, ethics committee, or other institutional body to which data requests may be sent.

b) If there are no restrictions, please upload the minimal anonymized data set necessary to replicate your study findings as either Supporting Information files or to a stable, public repository and provide us with the relevant URLs, DOIs, or accession numbers. Please see http://www.bmj.com/content/340/bmj.c181.long for guidelines on how to de-identify and prepare clinical data for publication. For a list of acceptable repositories, please see http://journals.plos.org/plosone/s/data-availability#loc-recommended-repositories.

We will update your Data Availability statement on your behalf to reflect the information you provide.

3. We note you have included a table to which you do not refer in the text of your manuscript. Please ensure that you refer to Table 1 and 7 in your text; if accepted, production will need this reference to link the reader to the Table.

[Note: HTML markup is below. Please do not edit.]

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer #1: Partly

Reviewer #2: Partly

**********

2. Has the statistical analysis been performed appropriately and rigorously?

Reviewer #1: No

Reviewer #2: Yes

**********

3. Have the authors made all data underlying the findings in their manuscript fully available?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #1: No

Reviewer #2: Yes

**********

4. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #1: Yes

Reviewer #2: Yes

**********

5. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #1: Introduction

References supporting the claim that people with SMI are at increased risk during a pandemic are not provided; while this statement has face validity, the authors should provide literature supporting this claim, even if it is only through referencing similar situations.

Methods

The data appear to rely solely on self-report of health behaviors; it is not clear whether these reports reflect actual behavior (historically, for example, self-reports about consumption of produce poorly reflect actual consumption). Better description of the OWLS subcohort is needed; current description does not meet research checklist guidelines (see Equator Network for details). Authors do not fully describe the questions in the survey instrument: no supplement with these details was included in the manuscript provided for review, nor was one mentioned in the text. Scaling of global health and wellbeing is rudimentary and given the potential overlap in underlying concepts, some estimation indicating whether these measures are loading together would be critical (e.g. factor analysis, SEQ). There is no indication of why a binary measure of race/ethnicity would be valid in this sample. No research supporting the decision to measure relative deprivation by postcode analysis is provided. Capitalize Poisson. 40.3% is not a majority; it is (apparently) a plurality. Critically, the specific dates used to define pre- and post-COVID periods are not provided.

Results

Response rate is not provided (please use standardized response rate from AAPOR or another comparable source). Race/ethnicity was proposed as a binary variable in methods but broken out by additional categories in results; this is inconsistent, and the choice of categories is not well-explained. Table 1 is difficult to read given that counts and percentages are placed in a single column; in addition, standard deviations for measures are not provided. Table 2 has similar issues, in addition, placing pre- and post-COVID variables vertically rather than horizontally makes it difficult to for the reader to assess changes. Table 4: unclear why univariate models are included at all; table formatting is challenging to read (eg CIs spread across multiple lines, significant associations not distinguished from non-significant with asterisks/bolding, spacing spreads results across multiple pages), and dependent variable is not explicitly stated. Associations between health-harming behaviors and deterioration raised questions of causality. It is unclear to what extent these behaviors would be unique to people with SMI.

Discussion

Comparisons in discussion suggest decreases in physical activity/increase in smoking but do not test for statistical significance, making it unclear whether these are meaningful. The sources of these claims are not linked to the results section (where the tests for significance should be reported). Links should be included as references not in the text of the manuscript. Conclusions re: the need for health services are not clearly linked to results.

Data availability

PLOS 1 historically requests that data underlying analysis be made available through a public repository, or, if held by an organization that limits access to data for reasons of confidentiality, for example a government agency that retains protected health information, that a detailed description of how to submit a formal data request and obtain a standardized dataset be provided, e.g. through a website with an explanation of what forms must be completed and what variables to request. The statement that data are “available upon request from the corresponding author” does not meet either standard.

Reviewer #2: This is an interesting manuscript dealing with a timely topic. Overall, it is well-conducted, although the authors should address several points.

Abstract

-Some information on the participants features should be provided (sex, age)

-There is no significant association between younger and an increase in health-risk behaviours since the IC comprises 1. This is not worth mentioning here.

Introduction

-It is mainly well-conducted, but I think that you should mention more relevant studies to support your argument. For instance, since the pandemic has affected health-risk behaviours in general population, this might be exacerbated in people with mental illness. Also, as a consequence of a lack of physical activity, mental health might be deteriorated

https://pubmed.ncbi.nlm.nih.gov/32581985/

https://pubmed.ncbi.nlm.nih.gov/32793013/

-An initial hypothesis based on your rationale should be provided

Methods

-Could you provide more information on your sampling framework. It seems as if you have been selecting individuals by those mentioned criteria, but that is not sampling.

-According to the procedure, only those who accepted were included in the study, thus there is a participation rate, I guess.

-Were the questions to assess health-related behaviours or self-reported changes validated?

-The way you explain why you use Poisson regression is too wordy. You don´t need to explain your prior plans

-Why did you select such covariates?

-Did you have missing values?

Results

-When you report decimals in your Tables, you should stick to always the same number of those

-Table 4 needs to report the confounders you adjusted your models

Discussion

-Your study has three clear bias that should be mentioned: recall bias, selection bias (not real sampling), and causal bias, since your design does not allow to reach causes

Conclusion

-It is the first time I see citations in a Conclusion

**********

6. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #1: No

Reviewer #2: No

[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.]

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step.

PLoS One. 2021 Oct 14;16(10):e0258349. doi: 10.1371/journal.pone.0258349.r002

Author response to Decision Letter 0


23 Aug 2021

a) If there are ethical or legal restrictions on sharing a de-identified data set, please explain them in detail (e.g., data contain potentially identifying or sensitive patient information) and who has imposed them (e.g., an ethics committee). Please also provide contact information for a data access committee, ethics committee, or other institutional body to which data requests may be sent.

We are not able to share a de-identified data set as we do not have consent from the research participants to do this. We have checked with the GDPR team at the University of York and they have advised us that we cannot upload this data to a public repository without explicit consent from the study participants. They did however advise us that we could upload an aggregated data set which we are planning to do. We have consulted with the Research Ethics Committee that approved our study and they confirmed that it would be acceptable for us to upload the aggregated dataset to a public repository. We are currently preparing the data set for uploading and will send you the link as soon as it is done. As this is COVID-19 research, we didn’t want to delay the processing of the responses to the other comments hence we have submitted them now.

Data requests for the full dataset may be sent to the Closing the Gap Network email: ctg-network@york.ac.uk whose Steering Committee manage our data access requests.

Reviewer One

Introduction

1. References supporting the claim that people with SMI are at increased risk during a pandemic are not provided; while this statement has face validity, the authors should provide literature supporting this claim, even if it is only through referencing similar situations.

We have added a citation to support the statement that people with SMI may be at increased risk. (https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7250778/)

Methods

2. The data appear to rely solely on self-report of health behaviors; it is not clear whether these reports reflect actual behavior (historically, for example, self-reports about consumption of produce poorly reflect actual consumption).

We agree that self-reported data is not always accurate however there is no clear way of collecting objective data on health risk behaviours, e.g. smoking status can be verified by CO measurement but this cannot tell us how many cigarettes a person is smoking per day. This means that we have had to reply on self-report data. We have stated this as a limitation in our discussion.

“Secondly, the survey relies on self-reported data and people may not accurately recall or may not want to accurately answer the question/s. However this is true for any form of survey that does not have a way of verifying the data provided. Thus the results should be interpreted with this in mind.”

3. Better description of the OWLS subcohort is needed; current description does not meet research checklist guidelines (see Equator Network for details).

We apologise for this oversight. We have now attached a completed STROBE checklist, added additional text (page 21) to explain how the sub-cohort relates to the original cohort and added a flow diagram (Figure 1).

“From the 2,932 participants in the CtG study that were eligible to be invited to OWLS, we selected a sample of 1,166 (39.8 %) participants to attempt to contact and successfully contacted 688 (59%). The survey was completed by 367 participants (31.5% of those eligible to be invited and 53.3% of those successfully contacted) see Figure 1.”

4. Authors do not fully describe the questions in the survey instrument: no supplement with these details was included in the manuscript provided for review, nor was one mentioned in the text.

We are sorry for this omission. We have included the survey as a supplementary file

5. Scaling of global health and wellbeing is rudimentary and given the potential overlap in underlying concepts, some estimation indicating whether these measures are loading together would be critical (e.g. factor analysis, SEQ).

We have amended the title on page 8 to “wellbeing” to provide greater clarity. These item under “wellbeing” are the four ONS Wellbeing questions. ”https://www.ons.gov.uk/peoplepopulationandcommunity/wellbeing/methodologies/surveysusingthe4officefornationalstatisticspersonalwellbeingquestions”

We have scaled these using the standard scaling used by the ONS. This measure is widely used in ONS general population surveys.

6. There is no indication of why a binary measure of race/ethnicity would be valid in this sample.

It is widely acknowledged that people from BAME groups are more at risk from COVID-19 and thus we wanted to test whether or not a person came from a minority group had any influence on behaviours harmful to health. We have added clarification about this to page 9.

“As people form BAME backgrounds are more at risk from COVID-19 we wanted to determine whether they were also more at risk from health risk behaviours.”

7. No research supporting the decision to measure relative deprivation by postcode analysis is provided.

We used this because this is how the UK Government and the Ministry of Housing and Communities measure relative deprivation. (https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/853811/IoD2019_FAQ_v4.pdf)

8. Capitalize Poisson

This has been corrected.

9. 40.3% is not a majority; it is (apparently) a plurality

We have removed the term “majority”

10. Critically, the specific dates used to define pre- and post-COVID periods are not provided.

We have clarified in the text on page 7 that before the pandemic refers to prior to the pandemic restrictions coming into force. In the results section we give the dates between which the participants completed the questionnaire (July 2020-December 2020) i.e. during the pandemic.

“In the questionnaire before the pandemic refers to before the pandemic restriction came into force in the UK on the 23rd March.”

Results

11. Response rate is not provided (please use standardized response rate from AAPOR or another comparable source).

This has now been provided in the flow chart in Figure 1.

12. Race/ethnicity was proposed as a binary variable in methods but broken out by additional categories in results; this is inconsistent, and the choice of categories is not well-explained.

We provide fuller demographics for the reader to have a fuller picture of the ethnicity composition of the study however in the model we categorised these into BAME and Non BAME for the reasons described in point 6.

13. Table 1 is difficult to read given that counts and percentages are placed in a single column; in addition, standard deviations for measures are not provided.

It is standard reporting to quote ‘n’ and ‘%’ in the same column. Where measures are continuous we have provided the mean and standard deviation. For catergorical variables were quote ‘n’ and ‘%’ for each category.

14. Table 2 has similar issues, in addition, placing pre- and post-COVID variables vertically rather than horizontally makes it difficult to for the reader to assess changes.

As the pre and post COVID variables are not the same it was unfortunately not possible to place them horizontally side by side.

15. Table 4: unclear why univariate models are included at all; table formatting is challenging to read (eg CIs spread across multiple lines, significant associations not distinguished from non-significant with asterisks/bolding, spacing spreads results across multiple pages), and dependent variable is not explicitly stated.

Thank you for this advice, we have deleted the results of the univariate model and the CIs are now all on one line. In addition we have asterisked the significant results.

16. Associations between health-harming behaviors and deterioration raised questions of causality.

We agree with this comment and acknowledge that we cannot determine causality.

“We do not know whether an increase in health risk behaviours led to a deterioration in physical health or whether a deterioration in physical health led to people being less able to take care of themselves, and this relationship is likely to be bidirectional.”

17. It is unclear to what extent these behaviors would be unique to people with SMI.

We agree that is it unclear to what extent these behaviours would be unique to people with SMI. We make comparisons to the general population throughout the discussion to provide context to the reader.

Discussion

18. Comparisons in discussion suggest decreases in physical activity/increase in smoking but do not test for statistical significance, making it unclear whether these are meaningful. The sources of these claims are not linked to the results section (where the tests for significance should be reported).

We were not able to test the changes in physical activity and smoking for significance as we didn’t have a pre and post measure. We captured the change via a single item for each behaviour which read “please let us know how each of the following habits might have changed since the pandemic restrictions began” with the possible responses “I don’t do that in general”, “More than usual”, “About the same” or “less than usual”.

19. Links should be included as references not in the text of the manuscript.

We have included the links as references.

Conclusions

20. re: the need for health services are not clearly linked to results.

Thank you we have removed the word ‘health’ and now state that there is a need for services that target health risk behaviours, we believe this to be the case as any increase in health risk behaviour needs to be addressed especially in a group already at risk from higher levels of health risk behaviours and the subsequent effects on both physical and mental health. Health risk behaviours are in part what is leading to the mortality gap people with SMI currently experience.

Data availability

21. PLOS 1 historically requests that data underlying analysis be made available through a public repository, or, if held by an organization that limits access to data for reasons of confidentiality, for example a government agency that retains protected health information, that a detailed description of how to submit a formal data request and obtain a standardized dataset be provided, e.g. through a website with an explanation of what forms must be completed and what variables to request. The statement that data are “available upon request from the corresponding author” does not meet either standard.

Unfortunately we do not have ethical permission to upload patient level data to a public repository. We will discuss with PLOS ONE what we are able to do.

Reviewer Two

Abstract

1. Some information on the participants features should be provided (sex, age)

We have added an additional sentence to the abstract with this information.

“The mean age was 50.5 (range = 20 to 86, SD ± 15.69) with 51.0% male and 77.4% white British”

2. There is no significant association between younger and an increase in health-risk behaviours since the IC comprises 1. This is not worth mentioning here.

Thank you, we have removed the reference to age as a significant association from the abstract.

Introduction

3. It is mainly well-conducted, but I think that you should mention more relevant studies to support your argument. For instance, since the pandemic has affected health-risk behaviours in general population, this might be exacerbated in people with mental illness. Also, as a consequence of a lack of physical activity, mental health might be deteriorated

https://pubmed.ncbi.nlm.nih.gov/32581985/

https://pubmed.ncbi.nlm.nih.gov/32793013/

Thank you these references have now been included.

4. An initial hypothesis based on your rationale should be provided

In this study we sought to explore the health risk behaviours of people with SMI during COVID-19. The study is an exploratory study and as such is not derived from any theoretical framework, therefore we had no specific hypothesis about how health risk behaviours in people with SMI might have changed. We have clarified this at the end of the introduction.

“This is an exploratory study rather than being derived from a theoretical framework.”

5. Could you provide more information on your sampling framework. It seems as if you have been selecting individuals by those mentioned criteria, but that is not sampling.

We have created a flow diagram and added some additional information about the sampling to the manuscript. See response to Reviewer One comment 3.

6. According to the procedure, only those who accepted were included in the study, thus there is a participation rate, I guess.

Yes, however we have now provided additional detail, see response to previous comment.

7. Were the questions to assess health-related behaviours or self-reported changes validated?

Questions to assess health related behaviours were self-reported, see response to Reviewer One comment 2.

8. The way you explain why you use Poisson regression is too wordy. You don´t need to explain your prior plans

We have included this for transparency as we have deviated from the plans in our pre-published analysis plan to prevent any future criticism about deviations from our plan.

9. Why did you select such covariates?

The aim of the analysis was to explore the association between the changes in health risk behaviours and changes in physical and mental health adjusting for key sample characteristics. We selected these variables based on experts in the field, statisticians and our lived experience panel.

10. Did you have missing values?

We have added details to Tables 1 and 2 regarding missing values.

Results

11. When you report decimals in your Tables, you should stick to always the same number of those.

Thank you for spotting this, this has now been corrected.

12. Table 4 needs to report the confounders you adjusted your models

Table 4 previously reported both the univariate and multivariate models and so the associations in the univariate models for each independent variable were adjusted for the presence of the other variables in the model. Following the advice of Reviewer One we removed the univariate models from Table 4.

Discussion

13. Your study has three clear bias that should be mentioned: recall bias, selection bias (not real sampling), and causal bias, since your design does not allow to reach causes

We have added an additional point to the limitations about recall bias (see response to reviewer one, point 2). We used a sampling framework to sample participants from our cohort, rather than use a convenience sample, we have acknowledged in the limitations section that we may not have been able to contact the most vulnerable section of the SMI population and the efforts we went to, to do all we could to include them. We have not sought to make any claims about causation and have clarified this in the limitations section.

“Thirdly, the design used in this study does not allow us to determine the causes of any changes in health related behaviours so we cannot be certain as to why behaviours might have changed.”

Conclusion

14. It is the first time I see citations in a Conclusion

We wanted to include these citations as we felt it was important for the reader to realise that we were not making statements that were not backed up by evidence.

Attachment

Submitted filename: Response to reviewers.docx

Decision Letter 1

Jagdish Khubchandani

27 Sep 2021

Health risk behaviours among people with severe mental ill health during the COVID-19 pandemic: analysis of linked cohort data

PONE-D-21-09538R1

Dear Dr. Peckham,

We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements.

Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication.

An invoice for payment will follow shortly after the formal acceptance. To ensure an efficient process, please log into Editorial Manager at http://www.editorialmanager.com/pone/, click the 'Update My Information' link at the top of the page, and double check that your user information is up-to-date. If you have any billing related questions, please contact our Author Billing department directly at authorbilling@plos.org.

If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org.

Kind regards,

Jagdish Khubchandani

Academic Editor

PLOS ONE

Additional Editor Comments (optional):

Thank you for the revisions and clarifications.

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. If the authors have adequately addressed your comments raised in a previous round of review and you feel that this manuscript is now acceptable for publication, you may indicate that here to bypass the “Comments to the Author” section, enter your conflict of interest statement in the “Confidential to Editor” section, and submit your "Accept" recommendation.

Reviewer #2: All comments have been addressed

**********

2. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer #2: Yes

**********

3. Has the statistical analysis been performed appropriately and rigorously?

Reviewer #2: Yes

**********

4. Have the authors made all data underlying the findings in their manuscript fully available?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #2: Yes

**********

5. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #2: Yes

**********

6. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #2: (No Response)

**********

7. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #2: No

Acceptance letter

Jagdish Khubchandani

5 Oct 2021

PONE-D-21-09538R1

Health risk behaviours among people with severe mental ill health during the COVID-19 pandemic: analysis of linked cohort data

Dear Dr. Peckham:

I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now with our production department.

If your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information please contact onepress@plos.org.

If we can help with anything else, please email us at plosone@plos.org.

Thank you for submitting your work to PLOS ONE and supporting open access.

Kind regards,

PLOS ONE Editorial Office Staff

on behalf of

Dr. Jagdish Khubchandani

Academic Editor

PLOS ONE

Associated Data

    This section collects any data citations, data availability statements, or supplementary materials included in this article.

    Supplementary Materials

    S1 Checklist

    (DOCX)

    S1 File

    (PDF)

    Attachment

    Submitted filename: Response to reviewers.docx

    Data Availability Statement

    Data cannot be shared publicly because we do not have permission from the Research Ethics Committee to publicly share participant level data. The data that support the findings of this study are available on request from the Closing the Gap Network email: ctg-network@york.ac.uk for researchers who meet the criteria for access to confidential data.


    Articles from PLoS ONE are provided here courtesy of PLOS

    RESOURCES